Skip to main content
. 2021 Oct 16;32(3):1506–1516. doi: 10.1007/s00330-021-08251-8

Table 3.

Factors attributing to mean tumor ADC

Factors: Proportion of variance in ADC predicted by these factors (LOOCV R2)
A. Hardware and acquisition parameters: 64.3%
  Repetition time (TR)*
  Echo time (TE)*
  Flip angle
  Pixel Bandwidth
  In plane resolution*
  Slice thickness
  Number of signal averages (NSA)*
  Maximum b-value*
  Number of b-values*
  Signal to noise ratio (SNR)*
  Scanner model*
  Magnetic field strength
B. Patient-intrinsic parameters 0.4%
  Age
  Sex
  cT-stage (assessed on baseline MRI)
  cN-stage (assessed on baseline MRI)
  Response to chemoradiotherapy (complete versus incomplete response)
  Tumor volume
C. Center 32.5%
  Umbrella variable to account for any additional unknown variations between centers (e.g., patient preparation protocols, types of coils used, fat suppression techniques, etc.)
  Significant parameters: center
All (A + B + C) combined 63.5%
  Significant parameters: center, age, TR, TE, in-plane resolution, slice thickness, NSA, maximum b-values, number of b-values, scanner model, and SNR

Further details of the regression analysis can be found in Supplementary Materials 2. The LOOCV R2 value is a leave-one-out cross-validated goodness-of-fit measure indicating the proportion of the variance in the dependent (i.e., ADC) variable that can be explained by the independent variables using a linear regression model

*Indicate the variables that were significant with a p value < 0.05 based on a likelihood ratio test. For continuous variables, all polynomial terms were tested jointly